12:00 AM
 | 
Jan 02, 2012
 |  BC Week In Review  |  Company News  |  Deals

RegeneRx deal

RegeneRx said that it is in "licensing and other product-related discussions" with four partners for RGN-259. RegeneRx said it will take cost-cutting steps to save cash until a deal is...

Read the full 140 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >